An update on essential tremor

Current Neurology and Neuroscience Reports

Volumn 9, Issue 4, 2009, Pages 273-277

  Elble, Rodger J ^a   Deuschl, Günther ^b  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CREATININE; HARMALINE; HARMAN; IBOGAINE; N ACETYLASPARTIC ACID; OCTANOL; PREGABALIN; PRIMIDONE; PROPRANOLOL; TOPIRAMATE; ANTICONVULSIVE AGENT;

AUTOSOMAL DOMINANT INHERITANCE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DRUG EFFICACY; DYSTONIA; ESSENTIAL TREMOR; HAND DISEASE; HAND TREMOR; HUMAN; LEWY BODY; MOTOR DYSFUNCTION; MOTOR UNIT POTENTIAL; NEUROPATHOLOGY; PARKINSON DISEASE; REVIEW; STEREOTAXIC SURGERY; THALAMUS VENTRAL NUCLEUS; TREATMENT RESPONSE; WEAKNESS; WRIST DISEASE; PATHOPHYSIOLOGY;

ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; COGNITION DISORDERS; DEEP BRAIN STIMULATION; DEMENTIA; ESSENTIAL TREMOR; HUMANS;

EID: 67651238855     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-009-0041-6     Document Type: Review

References (49)

1. Deuschl G, Bain P, Brin M: Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord 1998, 13(Suppl 3):2-23.
2. Whaley NR, PPtzke JD, Baba Y, et al.: Essential tremor: phenotypic expression in a clinical cohort. Parkinsonism Relat Disord 2007, 13:333-339.
3. Deuschl G, Wenzelburger R, Loffler K, et al.: Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 2000, 123(Pt8): 1568-1580.
4. Stolze H, Petersen G, Raethjen J, et al.: The gait disorder of advanced essential tremor. Brain 2001, 124(Pt 11):2278-2286.
5. Djaldetti R, Nageris BI, Lorberboym M, et al.: [(123)I]-FP-CIT SPECT and olfaction test in patients with combined postural and rest tremor. J Neural Transm 2008, 115:469-472.
6. Rajput A, Robinson CA, Rajput AH: Essential tremor course and disability: A clinicopathologic study of 20 cases. Neurology 2004, 62:932-936.
7. Ghaemi M, Raethjen J, Hilker R, et al.: Monosymptomatic resting tremor and Parkinson's disease: A multitracer positron emission tomographic study. Mov Disord 2002, 17:782-788.
8. Elble RJ: Essential tremor is a monosymptomatic disorder. Mov Disord 2002, 17:633-637.
9. Higginson CI, Wheelock VL, Levine D, et al.: Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction. J Clin Exp Neuropsychol 2008:1-6.
10. Benito-León J, Louis ED, Bermejo-Pareja F: Elderly-onset essential tremor is associated with dementia. Neurology 2006, 66:1500-1505.
11. Bermejo-Pareja F, Louis ED, Benito-Leon J: Risk of incident dementia in essential tremor: A population-based study. Mov Disord 2007, 22:1573-1580.
12. Chatterjee A, Jurewicz EC, Applegate LM, Louis ED: Personality in essential tremor: Further evidence of nonmotor manifestations of the disease. J Neurol Neurosurg Psychiatry 2004, 75:958-961.
13. Tan EK, Fook-Chong S, Lum SY, et al.: Non-motor manifestations in essential tremor: Use of a validated instrument to evaluate a wide spectrum of symptoms. Parkinsonism Relat Disord 2005, 11:375-380.
14. Louis ED, Bromley SM, Jurewicz EC, Watner D: Olfactory dysfunction in essential tremor: A deficit unrelated to disease duration or severity. Neurology 2002, 59:1631-1633.
15. Shah M, Findley L, Muhammed N, Hawkes C: Olfaction is normal in essential tremor and can be used to distinguish it from Parkinson's disease. Mov Disord 2005, 20(Suppl 10):S166.
16. Ondo WG, Sutton L, Dat Vuong K, et al.: Hearing impairment in essential tremor. Neurology 2003, 61:1093-1097.
17. Benito-Leon J, Louis ED, Bermejo-Pareja F: Reported hearing impairment in essential tremor: A population-based case-control study. Neuroepidemiology 2007, 29:213-217.
18. Lorenz D, Frederiksen H, Moises H, et al.: High concordance for essential tremor in monozygotic twins of old age. Neurology 2004, 62:208-211.
19. Deng H, Le W, Jankovic J: Genetics of essential tremor. Brain 2007, 130:1456-1464.
20. Stefansson H, Steinberg S, Petursson H, et al.: Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 2009, 41:277-279.
21. Louis ED, Jiang W, Pellegrino KM, et al.: Elevated blood harmane (1-methyl-9H-pyrido[3,4-b]indole) concentrations in essential tremor. Neurotoxicology 2008, 29:294-300.
22. Louis ED: Environmental epidemiology of essential tremor. Neuroepidemiology 2008, 31:139-149.
23. Louis ED, Vonsattel JP: The emerging neuropathology of essential tremor. Mov Disord 2008, 23:174-182.
24. Shill HA, Adler CH, Sabbagh MN, et al.: Pathologic findings in prospectively ascertained essential tremor subjects. Neurology 2008, 70(16 Pt 2):1452-1455.
25. Parkkinen L, Soininen H, Laakso M, Alafuzoff I: Alpha-synuclein pathology is highly dependent on the case selection. Neuropathol Appl Neurobiol 2001, 27:314-325.
26. Saito Y, Ruberu NN, Sawabe M, et al.: Lewy body-related alpha-synucleinopathy in aging. J Neuropathol Exp Neurol 2004, 63:742-749.
27. O'Hearn E, Molliver ME: The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: A model of indirect, trans-synaptic excitotoxicity. J Neurosci 1997, 17:8828-8841.
28. Deuschl G, Bergman H: Pathophysiology of nonparkinsonian tremors. Mov Disord 2002, 17(Suppl 3):S41-S48.
29. Elble RJ: Report from a U.S. conference on essential tremor. Mov Disord 2006, 21:2052-2061.
30. Zesiewicz TA, Tlble R, Louis ED, et al.: Practice parameter: therapies for essential tremor: Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2005, 64: 2008-2020.
31. Ondo WG, Jankovic J, Connor GS, et al.: Topiramate in essential tremor: a double-blind, placebo-controlled trial. Neurology 2006, 66:672-677.
32. Zesiewicz TA, Ward CL, Hauser RA, et al.: A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Mov Disord 2007, 22:1660-1663.
33. Lyons KE, Pahwa R: PharmacotherApy of essential tremor: an overview of existing and upcoming agents. CNS Drugs 2008, 22:1037-1045.
34. SimpsoB DM, Blitzer A, Brashear A, et al.: Assessment: botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008, 70:1699-1706.
35. Shill HA, Bushara KO, Mari Z, et al.: Open-label doseescalation study of oral 1-octanol in patients with essential tremor. Neurology 2004, 62:2320-2322.
36. Frucht SJ, Houghton WC, Bordelon Y, et al.: A single-blind, open-label trial of sodium oxybate for myoclonus and essential tremor. Neurology 2005, 65: 1967-1969.
37. Obwegeser AA, Uitti RJ, Turk MF, et al.: Thalamic stimulation for the treatment of midline tremors in essential tremor patients. Neurology 2000, 54:2342-2344.
38. Taha JM, Janszen MA, Favre J: Thalamic deep brain stimulation for the treatment of head, voice, and bilateral limb tremor. J Neurosurg 1999, 91:68-72.
39. Papavassiliou E, Rau G, Heath S, et al.: Thalamic deep brain stimulation for essential tremor: Relation of lead location to outcome. Neurosurgery 2008, 62(Suppl 2):884-894.
40. Pilitsis JG, Metman LV, Toleikis JR, et al.: Factors involved in long-term efficacy of deep brain stimulation of the thalamus for essential tremor. J Neurosurg 2008, 109:640-646.
41. Murata J, Kitagawa M, Uesugi H, et al.: Electrical stimulation of the posterior subthalamic area for the treatment of intractable proximal tremor. J Neurosurg 2003, 99:708-715.
42. Herzog J, Hamel W, Wenzelburger R, et al.: Kinematic analysis of thalamic versus subthalamic neurostimulation in postural and intention tremor. Brain 2007, 130(Pt 6):1608-1625.
43. Plaha P, Khan S, Gill SS: Bilateral stimulation of the caudal zona incerta nucleus for tremor control. J Neurol Neurosurg Psychiatry 2008, 79:504-513.
44. Stover NP, Okun MS, Evatt ML, et al.: Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor. Arch Neurol 2005, 62:141-143.
45. Constantoyannis C, Kumar A, Stoessl AJ, Honey CR: Tremor induced by thalamic deep brain stimulation in patients with complex regional facial pain. Mov Disord 2004, 19:933-936.
46. Earhart GM, Hong M, Tabbal SD, Perlmutter JS: Effects of thalamic stimulation frequency on intention and postural tremor. Exp Neurol 2007, 208:257-263.
47. Kondziolka D, Ong JG, Lee JY, et al.: Gamma knife thalamotomy for essential tremor. J Neurosurg 2008, 108:111-117.
48. Singleton AB, Farrer M, Johnson J, et al.: Alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
49. Benito-Leon E, Louis ED: Essential tremor: emerging views of a common disorder. Nat Clin Pract Neurol 2006, 2:666-678.